Drugs News and Research

RSS

Johns Hopkins researchers develop method to turn stem cells into retinal ganglion cells

Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. Death and dysfunction of these cells cause vision loss in conditions like glaucoma and multiple sclerosis.

1 Dec 2015

MPP collaborates with University of Liverpool to accelerate development of HIV nanomedicines

The Medicines Patent Pool today announced a collaboration with the University of Liverpool and a licence for the university's Solid Drug Nanoparticle (SDN) technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines.

30 Nov 2015

New Start Detox receives CARF Accreditation

New Start Detox has been issued a Three-Year CARF Accreditation. This achievement is an indication of New Start Detox's dedication and commitment to improving the quality of the lives of the people they serve. This Accreditation applies to: Detoxification: Alcohol and other Drugs/Addictions (Adults).

30 Nov 2015

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

In addition to their well established cholesterol lowering benefits, statins also have potent anti-inflammatory, anti-fibrotic and antioxidant effects, which continue to be identified in a wide range of diseases.

30 Nov 2015

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Elbit Imaging Ltd. announced today that it was informed by InSightec Ltd., that the Korean Ministry of Food and Drug Safety has approved its Exablate Neuro system to treat movement, pain and behavioral disorders.

30 Nov 2015

Researchers discover drug target and genetic pathway for graft-versus-host disease

A Seattle Children's Research Institute lab has discovered a genetic pathway that can be targeted with existing drugs to prevent graft-versus-host disease (GVHD), a common and deadly complication of bone marrow transplants.

30 Nov 2015

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.

30 Nov 2015

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

30 Nov 2015

Establishing supervised injection facilities in Toronto and Ottawa would be cost-effective, say researchers

Researchers say it is highly likely that establishing up to three supervised injection facilities in Toronto and up to two facilities in Ottawa would be cost-effective.

30 Nov 2015

Australian Government still refuses to admit failure of tobacco branding ban

On the third anniversary of Australia's controversial 'plain' packaging legislation for tobacco products, the Government is still refusing to admit its failure. This would explain why the Department of Health (DoH) is pushing back the publication of its Post-Implementation Review (PIR).

30 Nov 2015

Mallinckrodt sells CMDS business to Guerbet for $270 million

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.

28 Nov 2015

Prehospital combination therapy disappoints in status epilepticus

Adding levetiracetam to prehospital treatment with clonazepam does not improve control of generalised convulsive status epilepticus, shows a randomised phase III trial.

27 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015

Structured personal diabetes care improves outcomes in women

A follow-up study to assess the effects of personally tailored diabetes care in general practice has revealed that such care reduces mortality (both all-cause and diabetes-related), in women, but not men. The study is by Dr Marlene Krag, The Research Unit for General Practice, Department of Public Health, University of Copenhagen, Denmark, and colleagues, and is published in Diabetologia, the journal of the European Association for the Study of Diabetes.

27 Nov 2015

Scientists show how malaria parasites invade the liver

Scientists at the Center for Infectious Disease Research recently uncovered a critical piece in the puzzle of how malaria parasites infect their host. The work, recently published in Science Magazine, reveals the details of how the malaria parasite invades its initial target organ, the liver. Without infection of the liver, the parasites cannot multiply or spread to the blood. Infection of the blood causes illness, spread of the disease, and, ultimately, death.

27 Nov 2015

Researchers reveal new technique to grow human hepatocytes in the laboratory

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. This groundbreaking development could help advance a variety of liver-related research and applications, from studying drug toxicity to creating bio-artificial liver support for patients awaiting transplantations.

27 Nov 2015

Researchers examine CR rates in advanced cancer patients who receive cancer treatment

The researchers reported the results of a meta-analysis of 68 chemotherapy trials for cancer treatment between 2000 and 2006 - before the gradual introduction of targeted cancer therapies (drugs that target specific molecular pathways in tumour cells) from 2007, which today can be prescribed alongside cytotoxic drugs.

26 Nov 2015

New test can detect drug abuse faster

A new test for club drugs like ketamine can detect low levels of drugs in urine and plasma, making it faster, easier and cheaper to identify them. The authors of the study, published in Journal of Chromatography B, say it could give authorities the boost they need to keep up with trends drug (ab)use.

26 Nov 2015

Columbia University data scientists create world's first catalog of therapeutic venom

What doesn't kill you could cure you. A growing interest in the therapeutic value of animal venom has led a pair of Columbia University data scientists to create the first catalog of known animal toxins and their physiological effects on humans.

26 Nov 2015

Drugs News and Research

Johns Hopkins researchers develop method to turn stem cells into retinal ganglion cells

MPP collaborates with University of Liverpool to accelerate development of HIV nanomedicines

New Start Detox receives CARF Accreditation

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Researchers discover drug target and genetic pathway for graft-versus-host disease

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Heptares announces strategic drug discovery collaboration with Pfizer

Establishing supervised injection facilities in Toronto and Ottawa would be cost-effective, say researchers

Australian Government still refuses to admit failure of tobacco branding ban

Mallinckrodt sells CMDS business to Guerbet for $270 million

Prehospital combination therapy disappoints in status epilepticus

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Structured personal diabetes care improves outcomes in women

Scientists show how malaria parasites invade the liver

Researchers reveal new technique to grow human hepatocytes in the laboratory

Researchers examine CR rates in advanced cancer patients who receive cancer treatment

New test can detect drug abuse faster

Columbia University data scientists create world's first catalog of therapeutic venom

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News